Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

DocCheck AG
XETRA:AJ91

Watchlist Manager
DocCheck AG Logo
DocCheck AG
XETRA:AJ91
Watchlist
Price: 13.5 EUR -0.74% Market Closed
Market Cap: €68.4m
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one AJ91 stock under the Base Case scenario is 10.36 EUR. Compared to the current market price of 13.5 EUR, DocCheck AG is Overvalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AJ91 Relative Value
Base Case
10.36 EUR
Overvaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

AJ91 Competitors Multiples
DocCheck AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
DocCheck AG
XETRA:AJ91
68.5m EUR 1.3 13 5 6.8
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
US
Veeva Systems Inc
NYSE:VEEV
28.6B USD 9.3 33.2 23.6 24.6
AU
Pro Medicus Ltd
ASX:PME
12.3B AUD 56 107.2 73.5 73.5
JP
M3 Inc
TSE:2413
1.1T JPY 3.2 22.2 10.9 13.2
US
Doximity Inc
NYSE:DOCS
4.7B USD 7.2 19.3 15.4 16.3
SE
Sectra AB
STO:SECT B
35.5B SEK 15.9 55 -107.9 -107.9
US
Waystar Holding Corp
NASDAQ:WAY
3.9B USD 3.8 35.2 12.3 19.3
CN
Winning Health Technology Group Co Ltd
SZSE:300253
25.2B CNY 11.7 -81.9 -161.9 -161.9
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
281.4B INR 9.1 42.1 27.9 31.4
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328 267.9 4 290.1
P/E Multiple
Earnings Growth PEG
DE
DocCheck AG
XETRA:AJ91
Average P/E: 42.2
13
N/A N/A
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.2
32%
1
AU
Pro Medicus Ltd
ASX:PME
107.2
32%
3.3
JP
M3 Inc
TSE:2413
22.2
16%
1.4
US
Doximity Inc
NYSE:DOCS
19.3
17%
1.1
SE
Sectra AB
STO:SECT B
55
17%
3.2
US
W
Waystar Holding Corp
NASDAQ:WAY
35.2
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -81.9
69%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
42.1
N/A N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
DocCheck AG
XETRA:AJ91
Average EV/EBITDA: 51
5
N/A N/A
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
23.6
38%
0.6
AU
Pro Medicus Ltd
ASX:PME
73.5
32%
2.3
JP
M3 Inc
TSE:2413
10.9
14%
0.8
US
Doximity Inc
NYSE:DOCS
15.4
23%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -107.9 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
12.3
24%
0.5
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -161.9
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
27.9
137%
0.2
US
V
Vocera Communications Inc
F:V00
267.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
DocCheck AG
XETRA:AJ91
Average EV/EBIT: 502.1
6.8
N/A N/A
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
24.6
39%
0.6
AU
Pro Medicus Ltd
ASX:PME
73.5
31%
2.4
JP
M3 Inc
TSE:2413
13.2
N/A N/A
US
Doximity Inc
NYSE:DOCS
16.3
25%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -107.9 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
19.3
58%
0.3
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -161.9
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
31.4
N/A N/A
US
V
Vocera Communications Inc
F:V00
4 290.1
N/A N/A

See Also

Summary
AJ91 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AJ91 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AJ91 stock valuation using valuation multiples.
Wall Street Estimates
AJ91 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AJ91 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.